<custodian> <reference value="Organization/118079"/> <type value="Organization"/> <display value="Computable Publishing LLC"/> </custodian> <relatesTo> <type value="derived-from"/> <targetReference> <reference value="ResearchStudy/267245"/> <type value="ResearchStudy"/> <display value="A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example"/> </targetReference> </relatesTo> <relatesTo> <type value="cite-as"/> <targetMarkdown value="M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568069. Revised 2026-05-31. Available at: https://fevir.net/resources/Composition/568069. Computable resource at: https://fevir.net/resources/Composition/568069#json."/> </relatesTo> <section> <title value="Appendix: Supporting Details"/> <code> <coding> <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/> <code value="C218666"/> <display value="ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS"/> </coding> <text value="section12-supporting-details"/> </code> <text> <status value="empty"/><div xmlns="http://www.w3.org/1999/xhtml">[No text is intended here (heading only).]</div> </text> <section> <title value="Clinical Laboratory Tests"/> <code> <coding> <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/> <code value="C218667"/> <display value="ICH M11 Protocol Section 12.1 Clinical Laboratory Tests"/> </coding> <text value="section12.1-clinical-laboratory-tests"/> </code> <text> <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><p>7 pages of images replaced with this statement.</p></div> </text> </section> <section> <title value="Country/Region-Specific Differences"/> <code> <coding> <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/> <code value="C218668"/> <display value="ICH M11 Protocol Section 12.2 Country/Region-Specific Differences"/> </coding> <text value="section12.2-country-specific-differences"/> </code> <text> <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><p>Not applicable.</p></div> </text> </section> <section> <title value="Prior Protocol Amendment(s)"/> <code> <coding> <system value="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl"/> <code value="C218669"/> <display value="ICH M11 Protocol Section 12.3 Prior Protocol Amendment(s)"/> </coding> <text value="section12.3-prior-protocol-amendments"/> </code> <text> <status value="additional"/><div xmlns="http://www.w3.org/1999/xhtml"><p>Not applicable. This is the first protocol amendment.</p></div> </text> </section> </section> </Composition>

Generated Narrative: Composition 568069

version: 2; Last updated: 2026-05-31 00:21:11+0000

Profile: M11ReportSection12

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/Composition/568069

identifier: FEvIR Object Identifier/568069

status: Final

type: CeSHarP Report

category: section12-supporting-details

date: 2026-05-31 00:21:11+0000

author: Brian S. Alper, MD, MSPH

title: M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

custodian: Computable Publishing LLC

relatesTo
type: Derived From
target: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example

relatesTo
type: Cite As
target:
M11 Report Section 12 (Supporting Details) for A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 568069. Revised 2026-05-31. Available at: https://fevir.net/resources/Composition/568069. Computable resource at: https://fevir.net/resources/Composition/568069#json.